Chimpharm announces decision of Board of Directors to make interested party deals

/KASE, June 2, 2017/ – Chimpharm (Shymkent), whose shares are officially listed on Kazakhstan Stock Exchange (KASE), has by an official letter informed KASE of a May 30, 2017 decision of its Board of Directors – http://www.kase.kz/files/emitters/CHFM/chfm_reshenie_sd_300517.pdf [2017-06-02]